echo iq logo footer blk padding lg 01

Our mission

Echo IQ uses its AI-driven technology to enhance the diagnosis of structural heart disease. Our mission is to help reduce the number of patients currently being missed for life-saving and extending treatments.

#aiforgood

Our values

Innovation

By embracing smart ways of doing things and encouraging creativity.

Quality

By doing things with thought and great care.

Health & Wellbeing

By creating a positive environment for our people, and through life-enhancing technology solutions.

Performance

By striving for superior business results and pushing ourselves.

Partnership

By fostering a collaborative spirit with all our stakeholders.

 

 

 

Leadership Team

Andrew Grover

Andrew Grover
Executive Chair &
Managing Director

Philip Woolff

Philip Woolff
Chief Operating
Officer

Sean Bryceland

Seán Bryceland
Chief Technology
Officer

Deon Strydom

Deon Strydom
Chief Commercial
Officer

Prof. Geoff Strange

Prof. Geoff Strange
Chief Research &
Strategy Officer

Prof. David Playford

Prof. David Playford
Chief Medical Advisor

Jacki McAvenna

Jacki McAvenna
Chief Financial Officer

Dane Brescacin

Dane Brescacin
VP Regulatory Affairs

Rakesh Patel

Rakesh Patel
Technical Director,
MedTech

Scientific Advisory Board

Huon H. GrayX

CBE MD FRCP  FESC MACC

Huon Gray was consultant adult and interventional cardiologist at Southampton University Hospital from 1989 to 2020. In 2003 he was appointed President of the British Cardiac Society, receiving its Mackenzie Medal in 2014. 

Prof. Gray co-chaired the Dept. of Health’s National Infarct Angioplasty Project (2006-8), which led to the subsequent national roll out of primary PCI for ST elevation myocardial infarction in England. He was also clinical adviser and then chair of two NICE guidelines on acute coronary syndromes (2007-13). 

He is honorary professor at Queen Mary University, London and has published widely on various aspects of cardiology and health service delivery. He was Deputy and then Interim National Clinical Director for Heart Disease at the United Kingdom’s Department of Health (2007-12), co-producing its CVD Outcomes Strategy (2013), and was then National Clinical Director for Heart Disease in NHS England between 2013-19, helping develop the CVD priorities in the NHS Long Term Plan (2019). He was made Commander of the Excellent Order of the British Empire (CBE) in the Queen’s New Year’s Honours list 2019. 

Huon has served in various capacities within the American College of Cardiology (ACC); as chair of its International Council (2008-13), on its Board of Trustees (2012-16), as member of its Governance Committee (2016-19) and then its chair (2019-22). He received the ACC’s Presidential Citation in 2013 and designation as Master of the ACC in 2018.

David OuyangX

MD FACC FASE 

Dr. David Ouyang is a Los Angeles based cardiologist affiliated with the internationally recognised Cedars-Sinai Medical Center. He obtained his medical degree from the University of California (San Francisco) School of Medicine, residency and fellowship in Cardiovascular Medicine at Stanford University, and is Board Certified in Cardiovascular Disease and Internal Medicine. Dr. Ouyang has also completed post-doctoral studies in Computer Science and Biomedical Data Science at Stanford University. 

Having majored in Statistics (Rice University), Dr. Ouyang has always been fascinated by how to visualise and interpret data. He believes strongly in the opportunity to apply increases in data being collected to personalise care and improve diagnosis and treatment of cardiovascular disease. 

Dr. Ouyang was a competition finalist in the American Society of Echocardiography Arthur Weyman Young Investigator’s Award Competition and was awarded the 2018 Merck Research Fellowship at the American College of Cardiology Foundation. He received the Edwin Alderman Award for Excellence in Clinical Research in 2020. Expert in the statistical analysis of large datasets within cardiovascular medicine, he has produced a significant number of research publications that address deep learning and computer vision of cardiovascular imaging. 

Board of Directors

Andrew Grover

Andrew Grover
Executive Chair

Steve Formica

Steve Formica
Non-Executive Director

Steve Picton

Steve Picton
Non-Executive Director

Jessamyn Lyons

Jessamyn Lyons
Company Secretary

Contact us

Suite 404, 309 George Street, Sydney NSW 2000

All rights reserved. Copyright © Echo IQ 2021.

Suite 404, 309 George Street
Sydney NSW 2000

ABN 48 142 901 353

All rights reserved. Copyright © Echo IQ 2021.